Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/pharmaengine-inc-and-sentinel-oncology-limited-enter-into-an-exclusive-collaboration-and-license-agreement-for-sol-578-a-chk1-inhibitor-301186436.html#:~:text=(TWO%3A%204162)%20announced%20today,enabling%20studies%20for%20SOL%2D578.
https://www.prnewswire.com/news-releases/pharmaengine-inc-and-sentinel-oncology-limited-enter-into-an-exclusive-collaboration-and-license-agreement-for-sol-578-a-chk1-inhibitor-301186436.html